ClinicalTrials.gg
CompletedNCT07034989Updated Sep 24, 2025

Effectiveness of Telerehabilitation-Assisted Exercise Training

An interventional study of Exercise in Telerehabilitation and Exercise, sponsored by Zülal TATAR. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-24.

Sponsored by Zülal TATAR · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Mar 2025, registered Jun 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 995 studies in Motor Activity with a site in Turkey — 196 open to participants now, 225 under way, none of them phase 3. Motor Activity · Turkey.

Enrollment
757th of 768
10 · median 42
Started
2025
with 147 others
No phase
768 of 995
160 open now
Registered
744th of 995
by date

Among the 995 studies in Motor Activity with a site in Turkey, this one is the 757th largest by enrollment of the 768 interventional ones that give a count, is one of 148 that started in 2025, is one of 768 with no phase, and was the 744th registered.

Motor Activity

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

Browse Motor Activity studies →

Open to participants now

196 of the 995 studies in Motor Activity with a site in Turkey are open now. Recruiting first, the newest first:

191 more — sign in →

All 196 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,201 Motor Activity studies recruiting now, 517 (43%) set no upper age limit and 535 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 995 studies in Motor Activity with a site in Turkey, or all of them as a file.
02

Study summary

This study aimed to evaluate the effectiveness of asynchronously implemented telerehabilitation-supported respiratory physiotherapy and function-oriented trunk stabilization exercises, which have not been previously applied in individuals with RA-IAH.

03

Conditions studied

  • Telerehabilitation
  • Exercise

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with RA according to the 2010 EULAR/American College of Rheumatology diagnostic criteria
  • Individuals with RA-associated Interstitial Lung Disease
  • Individuals aged ≥18
  • Agreeing to attend regular training throughout the study
  • Having access to the internet and a computer

Exclusion criteria

Exclusion Criteria:

  • 10 pack-year smoking history
  • Surgery or arthroscopic surgery within the last year
  • Having any neurological or psychological disease that may prevent participation
  • Patient's inability to comply with evaluation and education
  • Having a psychiatric disease that will affect cooperation
  • Individuals with serious functional limitations and cardiopulmonary and/or neurological disease unrelated to RA
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
10 participants (actual)

Study arms

  • Active comparator
    Asynchronous exercise group

    Other: Exercise

  • No intervention
    Control Group

Interventions

  • OtherExercise

    Teach respiratory exercises and function-focused trunk stabilization exercises to individuals with RA-IAH via online platforms. Subsequently, instructional exercise videos will be delivered to the patients online. The respiratory exercise training will include thoracic expansion and diaphragmatic breathing exercises. The program will consist of a warm-up phase including 10 minutes of trunk stabilization exercises, a 40-minute functional exercise session targeting the upper and lower extremities with trunk stabilization, followed by a cooldown phase including 10 minutes of flexibility exercises involving trunk stabilization. The exercise videos related to these phases will be sent to the participants online. Participants will start the exercises with 6 repetitions and will be encouraged to increase to 8 repetitions as the program progresses. The assigned physiotherapist will contact patients once a week by phone to monitor exercise adherence.

06

What researchers measure

Primary outcomes

  1. Oxygen Saturation Measurement

    Time frame: Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.

Secondary outcomes

  1. Evaluation of respiratory muscle strength

    Time frame: Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.

  2. Modified Borg Scale

    Although it is frequently used today to define the severity of exertional dyspnea, it is also a scale that can be used to evaluate the severity of resting dyspnea. It consists of ten items that define the severity of dyspnea according to their degrees.

    Time frame: Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.

  3. Modified Medical Research Council Dyspnea Scale

    It is a scale based on various physical activities that cause dyspnea. It consists of five items. The patient rates respiratory distress between 0 (no shortness of breath) and 4 (shortness of breath during activities such as being homebound and dressing).

    Time frame: Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.

  4. Visual Analog Scale

    It consists of a 100 mm long horizontal line with the words "none" and "very severe" written on one end. The patient marks the severity of the current respiratory distress on the line using these two degrees as criteria. Scoring is done by measuring the marked area with the help of a tape measure.

    Time frame: Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.

  5. Leicester Cough Survey

    Measures the effect of cough on quality of life. It consists of 19 questions. It has psychological, social and physical sub-dimensions. The cut-off value of the scale is not defined; low scores indicate being more affected by cough, i.e. worse quality of life.

    Time frame: Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.

  6. St. George's Respiratory Survey

    It will be used to evaluate the health-related quality of life of the cases. SGRQ consists of three categories where the symptoms, activities and the effects of the disease on their daily lives are evaluated. The symptoms examined are cough, sputum, wheezing and shortness of breath. Physical functions, housework and hobbies are questioned to determine the activity status. These are activities limited by shortness of breath. The survey consisting of a total of 76 questions is completed in 20 minutes. There is an evaluation scale between zero and 100 points. Zero indicates perfect health status, 100 indicates the worst health status.

    Time frame: Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.

  7. Short Form-36 Quality of Life Survey

    Short form-36 is a quality of life scale consisting of 36 items that can be filled by the patient and whose validity and reliability have been shown in studies in patients with musculoskeletal disorders. The Turkish version of SF-36 was used in our study. This scale includes 8 separate health-related headings as physical function (10 items), social function (2 items), physical role limitation (4 items), emotional role limitation (3 items), mental health (5 items), vitality (4 items), pain (2 items), general health (6 items).

    Time frame: Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.

  8. Health Assessment Questionnaire

    Since it evaluates activities of daily living comprehensively and in all dimensions, HAQ was preferred in our study to assess the disability level. It includes 20 questions across 8 domains (dressing, arising, eating, walking, hygiene, reach, grip, and common activities). Each question is scored between 0 and 3 (without any difficulty = 0, with some difficulty = 1, with much difficulty = 2, unable to do = 3). The highest score of each subsection is summed up and divided by 8 to determine the total score between 0 and 3. A high score indicates a low functional level

    Time frame: Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.

  9. Disease Activity

    Disease activity in rheumatoid arthritis will be assessed using the Clinical Disease Activity Index (CDAI). This index is calculated based on four main parameters: the number of painful joints, the number of swollen joints, the visual analog scale of global disease activity as assessed by the patient, and the visual analog scale of global disease activity as assessed by the physician. CDAI scores of 0-2.8 indicate remission, 2.9-10 indicate low disease activity, 11-22 indicate moderate activity, and 22-76 indicate high activity.

    Time frame: Evaluations started immediately after receiving ethics committee approval and will be completed within 3 months, which is the study period.

07

Study locations

1 site
  • Pamukkale University
    Denizli, Malatya, Turkey (Türkiye)
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2025 to primary completion in Sep 2025, 6 months.

Of 5,147 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 6 months is below that.

Counting every sponsor, half of 5,207 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 11, 2025
First posted
Jun 24, 2025
StartActual
Mar 5, 2025
Primary completionActual
Sep 10, 2025
CompletionActual
Sep 20, 2025
Last update
Sep 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07034989
Lead sponsor
Zülal TATAR
Responsible party
Zülal TATAR (Researcher, Pamukkale University) — Sponsor-investigator
First posted
Jun 24, 2025
Start date
Mar 5, 2025
Primary completion
Sep 10, 2025
Completion
Sep 20, 2025
Last update
Sep 24, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion